Australia markets closed

Cytokinetics, Incorporated (CYTK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
65.34+0.54 (+0.83%)
At close: 04:00PM EDT
64.40 -0.94 (-1.44%)
After hours: 05:49PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts15151615
Avg. Estimate-1.14-1.12-4.45-3.29
Low estimate-1.35-1.36-5.42-5
High estimate-0.89-0.82-3.43-1.53
Year ago EPS-1.38-1.34-5.45-4.45
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts13131515
Avg. Estimate900k880k6.41M144.98M
Low estimateN/AN/AN/A5M
High estimate1.3M1.3M45.43M394.65M
Year ago sales4.61M5.8M7.53M6.41M
Sales growth (year/est)-80.50%-84.80%-14.90%2,161.80%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.2-1.15-0.74-0.97
Actual EPS-1.38-1.34-1.35-1.38
Difference-0.18-0.19-0.61-0.41
Surprise %-15.00%-16.50%-82.40%-42.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.14-1.12-4.45-3.29
7 days ago-1.14-1.12-4.45-3.29
30 days ago-1.14-1.12-4.46-3.31
60 days ago-1-1.02-4.53-3.3
90 days ago-1-1.02-4.53-3.3
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2222
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCYTKIndustrySector(s)S&P 500
Current qtr.17.40%N/AN/AN/A
Next qtr.16.40%N/AN/AN/A
Current year18.30%N/AN/AN/A
Next year26.10%N/AN/AN/A
Next 5 years (per annum)15.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A